CSL Ltd (CSL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CSL Ltd (CSL) has a cash flow conversion efficiency ratio of 0.114x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.44 Billion ≈ $1.73 Billion USD) by net assets (AU$21.48 Billion ≈ $15.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CSL net asset quality index to measure how much of total assets are equity-financed.
CSL Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how CSL Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CSL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CSL Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CSL Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Block, Inc
NYSE:XYZ
|
0.045x |
|
Holcim AG
SW:HOLN
|
0.152x |
|
Yum! Brands Inc
NYSE:YUM
|
-0.057x |
|
Ventas Inc
NYSE:VTR
|
0.030x |
|
Fortescue Ltd
AU:FMG
|
0.156x |
|
Erste Group Bank AG
VI:EBS
|
0.070x |
|
Ameriprise Financial Inc
NYSE:AMP
|
0.074x |
|
Rocket Lab USA Inc.
NASDAQ:RKLB
|
-0.022x |
Annual Cash Flow Conversion Efficiency for CSL Ltd (1993–2025)
The table below shows the annual cash flow conversion efficiency of CSL Ltd from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see CSL Ltd (CSL) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$21.41 Billion ≈ $15.15 Billion |
AU$3.56 Billion ≈ $2.52 Billion |
0.166x | +14.75% |
| 2024-06-30 | AU$19.40 Billion ≈ $13.73 Billion |
AU$2.81 Billion ≈ $1.99 Billion |
0.145x | -0.59% |
| 2023-06-30 | AU$26.78 Billion ≈ $18.95 Billion |
AU$3.91 Billion ≈ $2.76 Billion |
0.146x | -18.82% |
| 2022-06-30 | AU$21.20 Billion ≈ $15.00 Billion |
AU$3.81 Billion ≈ $2.69 Billion |
0.180x | -68.69% |
| 2021-06-30 | AU$8.42 Billion ≈ $5.96 Billion |
AU$4.83 Billion ≈ $3.42 Billion |
0.574x | +3.87% |
| 2020-06-30 | AU$6.53 Billion ≈ $4.62 Billion |
AU$3.61 Billion ≈ $2.55 Billion |
0.552x | +80.95% |
| 2019-06-30 | AU$5.27 Billion ≈ $3.73 Billion |
AU$1.61 Billion ≈ $1.14 Billion |
0.305x | -30.70% |
| 2018-06-30 | AU$4.10 Billion ≈ $2.90 Billion |
AU$1.81 Billion ≈ $1.28 Billion |
0.440x | +10.14% |
| 2017-06-30 | AU$3.16 Billion ≈ $2.24 Billion |
AU$1.27 Billion ≈ $895.30 Million |
0.400x | -13.70% |
| 2016-06-30 | AU$2.61 Billion ≈ $1.84 Billion |
AU$1.21 Billion ≈ $855.00 Million |
0.463x | -28.30% |
| 2015-06-30 | AU$2.09 Billion ≈ $1.48 Billion |
AU$1.35 Billion ≈ $955.34 Million |
0.646x | +50.61% |
| 2014-06-30 | AU$3.16 Billion ≈ $2.24 Billion |
AU$1.36 Billion ≈ $960.20 Million |
0.429x | -8.75% |
| 2013-06-30 | AU$3.01 Billion ≈ $2.13 Billion |
AU$1.41 Billion ≈ $1.00 Billion |
0.470x | +42.26% |
| 2012-06-30 | AU$3.55 Billion ≈ $2.51 Billion |
AU$1.17 Billion ≈ $830.42 Million |
0.331x | +26.49% |
| 2011-06-30 | AU$4.17 Billion ≈ $2.95 Billion |
AU$1.09 Billion ≈ $770.47 Million |
0.261x | -19.86% |
| 2010-06-30 | AU$3.02 Billion ≈ $2.14 Billion |
AU$984.78 Million ≈ $696.79 Million |
0.326x | +40.32% |
| 2009-06-30 | AU$3.52 Billion ≈ $2.49 Billion |
AU$819.29 Million ≈ $579.70 Million |
0.232x | -9.13% |
| 2008-06-30 | AU$2.68 Billion ≈ $1.90 Billion |
AU$686.77 Million ≈ $485.93 Million |
0.256x | +2.38% |
| 2007-06-30 | AU$1.63 Billion ≈ $1.15 Billion |
AU$407.51 Million ≈ $288.34 Million |
0.250x | -29.34% |
| 2006-06-30 | AU$1.09 Billion ≈ $771.10 Million |
AU$385.40 Million ≈ $272.69 Million |
0.354x | -1.48% |
| 2005-06-30 | AU$1.20 Billion ≈ $847.57 Million |
AU$430.00 Million ≈ $304.25 Million |
0.359x | +257.37% |
| 2004-06-30 | AU$1.45 Billion ≈ $1.03 Billion |
AU$145.66 Million ≈ $103.06 Million |
0.100x | -32.26% |
| 2003-06-30 | AU$586.80 Million ≈ $415.20 Million |
AU$87.02 Million ≈ $61.57 Million |
0.148x | +44.75% |
| 2002-06-30 | AU$716.77 Million ≈ $507.16 Million |
AU$73.43 Million ≈ $51.96 Million |
0.102x | -64.51% |
| 2001-06-30 | AU$229.78 Million ≈ $162.58 Million |
AU$66.33 Million ≈ $46.93 Million |
0.289x | +161.00% |
| 2000-06-30 | AU$284.37 Million ≈ $201.21 Million |
AU$31.45 Million ≈ $22.25 Million |
0.111x | -3.14% |
| 1999-06-30 | AU$184.19 Million ≈ $130.32 Million |
AU$21.03 Million ≈ $14.88 Million |
0.114x | -0.64% |
| 1998-06-30 | AU$149.53 Million ≈ $105.80 Million |
AU$17.19 Million ≈ $12.16 Million |
0.115x | -27.52% |
| 1997-06-30 | AU$273.59 Million ≈ $193.58 Million |
AU$43.38 Million ≈ $30.70 Million |
0.159x | -25.13% |
| 1996-06-30 | AU$212.25 Million ≈ $150.18 Million |
AU$44.96 Million ≈ $31.81 Million |
0.212x | +20.46% |
| 1995-06-30 | AU$167.67 Million ≈ $118.64 Million |
AU$29.48 Million ≈ $20.86 Million |
0.176x | +45.60% |
| 1994-06-30 | AU$231.32 Million ≈ $163.68 Million |
AU$27.94 Million ≈ $19.77 Million |
0.121x | -13.21% |
| 1993-06-30 | AU$70.25 Million ≈ $49.71 Million |
AU$9.78 Million ≈ $6.92 Million |
0.139x | -- |
About CSL Ltd
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more